NEA Management Company’s OnKure Therapeutics OKUR Stock Holding History

NEA Management Company’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Hold	478,548	–	–	0.14%	24
2026 Q1	$1.98M	Hold	478,548	–	–	0.11%	24
2025 Q4	$1.39M	Hold	478,548	–	–	0.07%	26
2025 Q3	$1.32M	Hold	478,548	–	–	0.07%	28
2025 Q2	$1.14M	Hold	478,548	–	–	0.09%	29
2025 Q1	$2.06M	Hold	478,548	–	–	0.16%	32
2024 Q4	$4.12M	Sell	478,548 -1	-0%	-$15	0.23%	33
2024 Q3	$8.14M	Hold	478,549	–	–	0.44%	30
2024 Q2	$7.23M	Hold	478,549	–	–	0.54%	29
2024 Q1	$7.94M	Hold	478,549	–	–	0.49%	31
2023 Q4	$7.66M	Hold	478,549	–	–	0.51%	31
2023 Q3	$36.4M	Hold	478,549	–	–	2.81%	11
2023 Q2	$28.3M	Hold	478,549	–	–	2.16%	15
2023 Q1	$28.6M	Hold	478,549	–	–	1.98%	16
2022 Q4	$11.2M	Sell	478,549 -143	-0%	-$3.79K	0.63%	28
2022 Q3	$16M	Hold	478,692	–	–	0.8%	31
2022 Q2	$12.7M	Hold	478,692	–	–	0.65%	32
2022 Q1	$14.1M	Hold	478,692	–	–	0.41%	33
2021 Q4	$40.9M	Hold	478,692	–	–	0.83%	20
2021 Q3	$35.7M	Hold	478,692	–	–	0.42%	22
2021 Q2	$44.7M	Buy	+478,692	New	+$53.4M	0.58%	25

Other funds holding OKUR

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NEA Management Company's OKUR Position: Q2 2026 in Review

NEA Management Company held its OnKure Therapeutics (OKUR) position steady in Q2 2026 at 478,548 shares worth $2.18M. The position accounts for 0.14% of the portfolio, ranked #24.

NEA Management Company first reported a position in OKUR in Q2 2021 and has held it in 21 quarters since. The position peaked at $44.7M in Q2 2021. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

NEA Management Company held 478,548 shares of OnKure Therapeutics worth $2.18M as of Q2 2026.
NEA Management Company left its OnKure Therapeutics share count unchanged in Q2 2026.
OnKure Therapeutics made up 0.14% of NEA Management Company's portfolio in Q2 2026, its #24 holding.
NEA Management Company first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 21 quarters since.
NEA Management Company's OnKure Therapeutics position peaked at $44.7M in Q2 2021.
75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on NEA Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.